Pharma news
Americas
UK-based drugmaker Shire plc announced on November 11 that it had acquired rare disease biopharmaceutical company ViroPharma in an agreement worth approximately $4.2 billion. 12 November 2013
Americas
US pharmaceutical company Forest Laboratories and drug company Actavis have settled a legal dispute over a patent protecting blood pressure drug Bystoli (nebivolol). 8 November 2013
Americas
A US trademark for Botulex would be too confusingly similar to Botox if granted, the Trademark Trial and Appeal Board has ruled. 6 November 2013
Asia
The Indian Patent Office has rejected an application for a compulsory licence that was filed by domestic drug maker BDR Pharmaceuticals. 31 October 2013
Asia
A court appeal by Bayer against India’s first ever compulsory licence on its patented cancer drug will start today, October 29. 29 October 2013
Pharma
Mr Justice Arnold has refused to recuse himself from a patent trial after he was accused of being conflicted by an expert witness. 28 October 2013
Pharma
UK-based pharmaceutical company AstraZeneca announced on October 15 that its biologics R&D subsidiary MedImmune had acquired cancer drug maker Spirogen. 18 October 2013
Pharma
Patent litigator Jonathan Radcliffe has left Mayer Brown to become partner at Charles Russell LLP. 16 October 2013
Asia
LSIPR spoke to Jörg Thomaier, chief IP counsel at Bayer, about the state of protection in emerging jurisdictions and the challenges the global company faces in asserting its IP across the world. 16 October 2013
Asia
Many of the world’s biggest selling drugs have lost exclusivity in recent years, presenting huge opportunities for generic drugs companies but, as LSIPR finds out, it doesn’t have to be a dead end for the innovators. 16 October 2013